The Veterans Affairs department launched the CRAVE trial on July 30, 2026, to test whether GLP-1 medications like Ozempic and Wegovy can treat alcohol use disorder in veterans. The trial explores whether weight-loss drugs can reduce alcohol consumption.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
The VA has launched a trial to test Ozempic and Wegovy for alcohol use disorder in veterans.
The new Cessation or Reduction of Alcohol Consumption in Veterans trial, or “CRAVE trial,” will see if the popular weight loss drug can curb alcohol use. The post VA to test whether GLP-1s can treat alcohol use disorder appeared first on Task & Purpose .